CSIMarket
 


Precigen Inc   (PGEN)
Other Ticker:  
 

Cumulative Precigen Inc 's Total Debt to Equity for Trailing Twelve Months Period

PGEN's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

PGEN Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -6.15 % 3.61 % 198.65 % 149.38 % 17.62 %
Y / Y Total Debt Growth - - - -93.14 % -76.4 %
Total Debt to Equity for Trailing Twelve Months Period 0.02 0.09 0.22 0.66 1.32
Total Ranking # # # # #
Seq. Equity Growth -19.76 % -11.15 % -9.73 % 45.84 % -11.42 %
Seq. Total Debt Growth - - - -68.03 % -47.34 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis In the IV. Quarter Precigen Inc did not have Total Debt .
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry Precigen Inc achieved the lowest Total Debt to Equity for Trailing Twelve Months Period. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
PGEN Charts and Quotes
Total Debt to Equity PGEN in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Rvl Pharmaceuticals Plc  0.06 
Celyad Oncology Sa  0.06 
Atai Life Sciences N v   0.06 
Trevi Therapeutics Inc   0.06 
Prophase Labs Inc   0.05 
Thorne Healthtech Inc   0.05 
Spruce Biosciences Inc   0.05 
Akero Therapeutics Inc   0.05 
Tenax Therapeutics Inc   0.05 
Novabay Pharmaceuticals Inc   0.05 
China Health Industries Holdings Inc   0.05 
Alx Oncology Holdings Inc  0.04 
Gain Therapeutics inc  0.04 
Kezar Life Sciences Inc   0.04 
Galmed Pharmaceuticals Ltd   0.04 
Gracell Biotechnologies Inc   0.04 
Dr Reddy s Laboratories Limited  0.04 
Protagenic Therapeutics Inc new  0.03 
Salarius Pharmaceuticals inc   0.03 
Flora Growth Corp   0.03 
Sonoma Pharmaceuticals Inc   0.03 
Nanoviricides inc   0.02 
Kura Oncology Inc   0.02 
Pliant Therapeutics Inc   0.02 
Altimmune Inc   0.02 
Puretech Health Plc  0.02 
Hookipa Pharma inc   0.02 
Oragenics Inc   0.02 
Shuttle Pharmaceuticals Holdings Inc   0.01 
Qilian International Holding Group Limited  0.01 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com